{
    "title": "Pharmacological studies on a new dihydrothienopyridine calcium antagonist, S-312-d. 5th communication: anticonvulsant effects in mice.",
    "abst": "S-312, S-312-d, but not S-312-l, L-type calcium channel antagonists, showed anticonvulsant effects on the audiogenic tonic convulsions in DBA/2 mice; and their ED50 values were 18.4 (12.8-27.1) mg/kg, p.o. and 15.0 (10.2-23.7) mg/kg, p.o., respectively, while that of flunarizine was 34.0 (26.0-44.8) mg/kg, p.o. Although moderate anticonvulsant effects of S-312-d in higher doses were observed against the clonic convulsions induced by pentylenetetrazole (85 mg/kg, s.c.) or bemegride (40 mg/kg, s.c.), no effects were observed in convulsions induced by N-methyl-D-aspartate, picrotoxin, or electroshock in Slc:ddY mice. S-312-d may be useful in the therapy of certain types of human epilepsy.",
    "title_plus_abst": "Pharmacological studies on a new dihydrothienopyridine calcium antagonist, S-312-d. 5th communication: anticonvulsant effects in mice. S-312, S-312-d, but not S-312-l, L-type calcium channel antagonists, showed anticonvulsant effects on the audiogenic tonic convulsions in DBA/2 mice; and their ED50 values were 18.4 (12.8-27.1) mg/kg, p.o. and 15.0 (10.2-23.7) mg/kg, p.o., respectively, while that of flunarizine was 34.0 (26.0-44.8) mg/kg, p.o. Although moderate anticonvulsant effects of S-312-d in higher doses were observed against the clonic convulsions induced by pentylenetetrazole (85 mg/kg, s.c.) or bemegride (40 mg/kg, s.c.), no effects were observed in convulsions induced by N-methyl-D-aspartate, picrotoxin, or electroshock in Slc:ddY mice. S-312-d may be useful in the therapy of certain types of human epilepsy.",
    "pubmed_id": "7967231",
    "entities": [
        [
            75,
            82,
            "S-312-d",
            "Chemical",
            "C059447"
        ],
        [
            135,
            140,
            "S-312",
            "Chemical",
            "C059447"
        ],
        [
            142,
            149,
            "S-312-d",
            "Chemical",
            "C059447"
        ],
        [
            175,
            182,
            "calcium",
            "Chemical",
            "D002118"
        ],
        [
            241,
            269,
            "audiogenic tonic convulsions",
            "Disease",
            "D020195"
        ],
        [
            403,
            414,
            "flunarizine",
            "Chemical",
            "D005444"
        ],
        [
            492,
            499,
            "S-312-d",
            "Chemical",
            "C059447"
        ],
        [
            549,
            560,
            "convulsions",
            "Disease",
            "D012640"
        ],
        [
            572,
            590,
            "pentylenetetrazole",
            "Chemical",
            "D010433"
        ],
        [
            611,
            620,
            "bemegride",
            "Chemical",
            "D001534"
        ],
        [
            667,
            678,
            "convulsions",
            "Disease",
            "D012640"
        ],
        [
            690,
            710,
            "N-methyl-D-aspartate",
            "Chemical",
            "D016202"
        ],
        [
            712,
            722,
            "picrotoxin",
            "Chemical",
            "D010852"
        ],
        [
            757,
            764,
            "S-312-d",
            "Chemical",
            "C059447"
        ],
        [
            820,
            828,
            "epilepsy",
            "Disease",
            "D004827"
        ]
    ],
    "split_sentence": [
        "Pharmacological studies on a new dihydrothienopyridine calcium antagonist, S-312-d.",
        "5th communication: anticonvulsant effects in mice.",
        "S-312, S-312-d, but not S-312-l, L-type calcium channel antagonists, showed anticonvulsant effects on the audiogenic tonic convulsions in DBA/2 mice; and their ED50 values were 18.4 (12.8-27.1) mg/kg, p.o. and 15.0 (10.2-23.7) mg/kg, p.o., respectively, while that of flunarizine was 34.0 (26.0-44.8) mg/kg, p.o.",
        "Although moderate anticonvulsant effects of S-312-d in higher doses were observed against the clonic convulsions induced by pentylenetetrazole (85 mg/kg, s.c.) or bemegride (40 mg/kg, s.c.), no effects were observed in convulsions induced by N-methyl-D-aspartate, picrotoxin, or electroshock in Slc:ddY mice.",
        "S-312-d may be useful in the therapy of certain types of human epilepsy."
    ],
    "if_txt_length_is_changed_flag": 0,
    "lines": [
        "C059447\tChemical\tS-312-d\tPharmacological studies on a new dihydrothienopyridine calcium antagonist , <target> S-312-d </target> .",
        "C059447\tChemical\tS-312\t<target> S-312 </target> , S-312-d , but not S-312-l , L-type calcium channel antagonists , showed anticonvulsant effects on the audiogenic tonic convulsions in DBA/2 mice ; and their ED50 values were 18.4 ( 12.8 - 27.1 ) mg/kg , p.o . and 15.0 ( 10.2 - 23.7 ) mg/kg , p.o . , respectively , while that of flunarizine was 34.0 ( 26.0 - 44.8 ) mg/kg , p.o .",
        "C059447\tChemical\tS-312-d\tS-312 , <target> S-312-d </target> , but not S-312-l , L-type calcium channel antagonists , showed anticonvulsant effects on the audiogenic tonic convulsions in DBA/2 mice ; and their ED50 values were 18.4 ( 12.8 - 27.1 ) mg/kg , p.o . and 15.0 ( 10.2 - 23.7 ) mg/kg , p.o . , respectively , while that of flunarizine was 34.0 ( 26.0 - 44.8 ) mg/kg , p.o .",
        "D002118\tChemical\tcalcium\tS-312 , S-312-d , but not S-312-l , L-type <target> calcium </target> channel antagonists , showed anticonvulsant effects on the audiogenic tonic convulsions in DBA/2 mice ; and their ED50 values were 18.4 ( 12.8 - 27.1 ) mg/kg , p.o . and 15.0 ( 10.2 - 23.7 ) mg/kg , p.o . , respectively , while that of flunarizine was 34.0 ( 26.0 - 44.8 ) mg/kg , p.o .",
        "D020195\tDisease\taudiogenic tonic convulsions\tS-312 , S-312-d , but not S-312-l , L-type calcium channel antagonists , showed anticonvulsant effects on the <target> audiogenic tonic convulsions </target> in DBA/2 mice ; and their ED50 values were 18.4 ( 12.8 - 27.1 ) mg/kg , p.o . and 15.0 ( 10.2 - 23.7 ) mg/kg , p.o . , respectively , while that of flunarizine was 34.0 ( 26.0 - 44.8 ) mg/kg , p.o .",
        "D005444\tChemical\tflunarizine\tS-312 , S-312-d , but not S-312-l , L-type calcium channel antagonists , showed anticonvulsant effects on the audiogenic tonic convulsions in DBA/2 mice ; and their ED50 values were 18.4 ( 12.8 - 27.1 ) mg/kg , p.o . and 15.0 ( 10.2 - 23.7 ) mg/kg , p.o . , respectively , while that of <target> flunarizine </target> was 34.0 ( 26.0 - 44.8 ) mg/kg , p.o .",
        "C059447\tChemical\tS-312-d\tAlthough moderate anticonvulsant effects of <target> S-312-d </target> in higher doses were observed against the clonic convulsions induced by pentylenetetrazole ( 85 mg/kg , s.c . ) or bemegride ( 40 mg/kg , s.c . ) , no effects were observed in convulsions induced by N-methyl-D-aspartate , picrotoxin , or electroshock in Slc : ddY mice .",
        "D012640\tDisease\tconvulsions\tAlthough moderate anticonvulsant effects of S-312-d in higher doses were observed against the clonic <target> convulsions </target> induced by pentylenetetrazole ( 85 mg/kg , s.c . ) or bemegride ( 40 mg/kg , s.c . ) , no effects were observed in convulsions induced by N-methyl-D-aspartate , picrotoxin , or electroshock in Slc : ddY mice .",
        "D010433\tChemical\tpentylenetetrazole\tAlthough moderate anticonvulsant effects of S-312-d in higher doses were observed against the clonic convulsions induced by <target> pentylenetetrazole </target> ( 85 mg/kg , s.c . ) or bemegride ( 40 mg/kg , s.c . ) , no effects were observed in convulsions induced by N-methyl-D-aspartate , picrotoxin , or electroshock in Slc : ddY mice .",
        "D001534\tChemical\tbemegride\tAlthough moderate anticonvulsant effects of S-312-d in higher doses were observed against the clonic convulsions induced by pentylenetetrazole ( 85 mg/kg , s.c . ) or <target> bemegride </target> ( 40 mg/kg , s.c . ) , no effects were observed in convulsions induced by N-methyl-D-aspartate , picrotoxin , or electroshock in Slc : ddY mice .",
        "D012640\tDisease\tconvulsions\tAlthough moderate anticonvulsant effects of S-312-d in higher doses were observed against the clonic convulsions induced by pentylenetetrazole ( 85 mg/kg , s.c . ) or bemegride ( 40 mg/kg , s.c . ) , no effects were observed in <target> convulsions </target> induced by N-methyl-D-aspartate , picrotoxin , or electroshock in Slc : ddY mice .",
        "D016202\tChemical\tN-methyl-D-aspartate\tAlthough moderate anticonvulsant effects of S-312-d in higher doses were observed against the clonic convulsions induced by pentylenetetrazole ( 85 mg/kg , s.c . ) or bemegride ( 40 mg/kg , s.c . ) , no effects were observed in convulsions induced by <target> N-methyl-D-aspartate </target> , picrotoxin , or electroshock in Slc : ddY mice .",
        "D010852\tChemical\tpicrotoxin\tAlthough moderate anticonvulsant effects of S-312-d in higher doses were observed against the clonic convulsions induced by pentylenetetrazole ( 85 mg/kg , s.c . ) or bemegride ( 40 mg/kg , s.c . ) , no effects were observed in convulsions induced by N-methyl-D-aspartate , <target> picrotoxin </target> , or electroshock in Slc : ddY mice .",
        "C059447\tChemical\tS-312-d\t<target> S-312-d </target> may be useful in the therapy of certain types of human epilepsy .",
        "D004827\tDisease\tepilepsy\tS-312-d may be useful in the therapy of certain types of human <target> epilepsy </target> ."
    ],
    "lines_lemma": [
        "C059447\tChemical\tS-312-d\tpharmacological study on a new dihydrothienopyridine calcium antagonist , <target> s-312-d </target> .",
        "C059447\tChemical\tS-312\t<target> s-312 </target> , s-312-d , but not s-312-l , l-type calcium channel antagonist , show anticonvulsant effect on the audiogenic tonic convulsion in dba/2 mouse ; and their ed50 value be 18.4 ( 12.8 - 27.1 ) mg/kg , p.o . and 15.0 ( 10.2 - 23.7 ) mg/kg , p.o . , respectively , while that of flunarizine be 34.0 ( 26.0 - 44.8 ) mg/kg , p.o .",
        "C059447\tChemical\tS-312-d\ts-312 , <target> s-312-d </target> , but not s-312-l , l-type calcium channel antagonist , show anticonvulsant effect on the audiogenic tonic convulsion in dba/2 mouse ; and their ed50 value be 18.4 ( 12.8 - 27.1 ) mg/kg , p.o . and 15.0 ( 10.2 - 23.7 ) mg/kg , p.o . , respectively , while that of flunarizine be 34.0 ( 26.0 - 44.8 ) mg/kg , p.o .",
        "D002118\tChemical\tcalcium\ts-312 , s-312-d , but not s-312-l , l-type <target> calcium </target> channel antagonist , show anticonvulsant effect on the audiogenic tonic convulsion in dba/2 mouse ; and their ed50 value be 18.4 ( 12.8 - 27.1 ) mg/kg , p.o . and 15.0 ( 10.2 - 23.7 ) mg/kg , p.o . , respectively , while that of flunarizine be 34.0 ( 26.0 - 44.8 ) mg/kg , p.o .",
        "D020195\tDisease\taudiogenic tonic convulsions\ts-312 , s-312-d , but not s-312-l , l-type calcium channel antagonist , show anticonvulsant effect on the <target> audiogenic tonic convulsion </target> in dba/2 mouse ; and their ed50 value be 18.4 ( 12.8 - 27.1 ) mg/kg , p.o . and 15.0 ( 10.2 - 23.7 ) mg/kg , p.o . , respectively , while that of flunarizine be 34.0 ( 26.0 - 44.8 ) mg/kg , p.o .",
        "D005444\tChemical\tflunarizine\ts-312 , s-312-d , but not s-312-l , l-type calcium channel antagonist , show anticonvulsant effect on the audiogenic tonic convulsion in dba/2 mouse ; and their ed50 value be 18.4 ( 12.8 - 27.1 ) mg/kg , p.o . and 15.0 ( 10.2 - 23.7 ) mg/kg , p.o . , respectively , while that of <target> flunarizine </target> be 34.0 ( 26.0 - 44.8 ) mg/kg , p.o .",
        "C059447\tChemical\tS-312-d\talthough moderate anticonvulsant effect of <target> s-312-d </target> in high dose be observe against the clonic convulsion induce by pentylenetetrazole ( 85 mg/kg , s.c . ) or bemegride ( 40 mg/kg , s.c . ) , no effect be observe in convulsion induce by n-methyl-d-aspartate , picrotoxin , or electroshock in Slc : ddy mouse .",
        "D012640\tDisease\tconvulsions\talthough moderate anticonvulsant effect of s-312-d in high dose be observe against the clonic <target> convulsion </target> induce by pentylenetetrazole ( 85 mg/kg , s.c . ) or bemegride ( 40 mg/kg , s.c . ) , no effect be observe in convulsion induce by n-methyl-d-aspartate , picrotoxin , or electroshock in Slc : ddy mouse .",
        "D010433\tChemical\tpentylenetetrazole\talthough moderate anticonvulsant effect of s-312-d in high dose be observe against the clonic convulsion induce by <target> pentylenetetrazole </target> ( 85 mg/kg , s.c . ) or bemegride ( 40 mg/kg , s.c . ) , no effect be observe in convulsion induce by n-methyl-d-aspartate , picrotoxin , or electroshock in Slc : ddy mouse .",
        "D001534\tChemical\tbemegride\talthough moderate anticonvulsant effect of s-312-d in high dose be observe against the clonic convulsion induce by pentylenetetrazole ( 85 mg/kg , s.c . ) or <target> bemegride </target> ( 40 mg/kg , s.c . ) , no effect be observe in convulsion induce by n-methyl-d-aspartate , picrotoxin , or electroshock in Slc : ddy mouse .",
        "D012640\tDisease\tconvulsions\talthough moderate anticonvulsant effect of s-312-d in high dose be observe against the clonic convulsion induce by pentylenetetrazole ( 85 mg/kg , s.c . ) or bemegride ( 40 mg/kg , s.c . ) , no effect be observe in <target> convulsion </target> induce by n-methyl-d-aspartate , picrotoxin , or electroshock in Slc : ddy mouse .",
        "D016202\tChemical\tN-methyl-D-aspartate\talthough moderate anticonvulsant effect of s-312-d in high dose be observe against the clonic convulsion induce by pentylenetetrazole ( 85 mg/kg , s.c . ) or bemegride ( 40 mg/kg , s.c . ) , no effect be observe in convulsion induce by <target> n-methyl-d-aspartate </target> , picrotoxin , or electroshock in Slc : ddy mouse .",
        "D010852\tChemical\tpicrotoxin\talthough moderate anticonvulsant effect of s-312-d in high dose be observe against the clonic convulsion induce by pentylenetetrazole ( 85 mg/kg , s.c . ) or bemegride ( 40 mg/kg , s.c . ) , no effect be observe in convulsion induce by n-methyl-d-aspartate , <target> picrotoxin </target> , or electroshock in Slc : ddy mouse .",
        "C059447\tChemical\tS-312-d\t<target> s-312-d </target> may be useful in the therapy of certain type of human epilepsy .",
        "D004827\tDisease\tepilepsy\ts-312-d may be useful in the therapy of certain type of human <target> epilepsy </target> ."
    ]
}